References
- Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20
- Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-17
- Jones R, Liker HR, Ducrotté P. Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract 2007;61:1301-7
- Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004;22:108-14
- Wiklund I, Carlsson J, Vakil N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am J Gastroenterol 2006;101:18-28
- Wahlqvist P, Guyatt GH, Armstrong D, et al. The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation. Pharmacoeconomics 2007;25:385-96
- Gisbert JP, Cooper A, Karagiannis D, et al. Consultation rates and characteristics of gastroesophageal reflux disease in primary care: a European observational study. Eur J Gen Pract 2009; in press
- Gisbert JP, Cooper A, Karagiannis D, et al. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 2009;7:60
- Seifert B, Rubin G, de Wit N, et al. The management of common gastrointestinal disorders in general practice. A survey by the European Society for Primary Care Gastroenterology (ESPCG) in six European countries. Dig Liver Dis 2008;40:659-66
- Jian R, Hassani Z, El Kebir S, et al. Management of gastro-esophageal reflux disease in primary care. Results from an observational study of 2,474 patients (AO). Gastroenterol Clin Biol 2007;31:72-7
- Fass R, Shapiro M, Dekel R, et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease - where next?. Aliment Pharmacol Ther 2005;22:79-94
- Gunaratnam NT, Jessup TP, Inadomi J, et al. Sub-optimal proton pump inhibitor dosing is prevalent in patients with poorly controlled gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;23:1473-7
- Hatlebakk JG, Katz PO, Camacho-Lobato L, et al. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Aliment Pharmacol Ther 2000;14:1267-72
- Dent J, Jones R, Vakil N, et al. A management strategy for GERD based on the Gastroesophageal Reflux Disease Questionnaire (GerdQ) [abstract]. Scand J Gastroenterol 2008;43:34-5
- Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001;96:52-7
- Svedlund J, Sjodin I, Dotevall G. GSRS -- a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129-34
- Jones R, Coyne K, Wiklund I. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007;25:1451-9
- Rey E, Moreno Elola-Olaso C, Rodriguez Artalejo F, et al. Impact of gastroesophageal reflux symptoms on health resource usage and work absenteeism in Spain. Rev Esp Enferm Dig 2006;98:518-26
- Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383-91
- De Giorgi F, Savarese MF, Atteo E, et al. Medical treatment of gastro-oesophageal reflux disease. Acta Otorhinolaryngol Ital 2006;26:276-80
- King A, MacDonald C, Örn C. Understanding gastro-oesophageal reflux disease: a patient-cluster analysis. Int J Clin Pract 2008;62:1838-43